159 related articles for article (PubMed ID: 10805105)
1. Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis.
Kuru S; Inukai A; Liang Y; Doyu M; Takano A; Sobue G
Acta Neuropathol; 2000 May; 99(5):585-8. PubMed ID: 10805105
[TBL] [Abstract][Full Text] [Related]
2. Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies.
Kuru S; Inukai A; Kato T; Liang Y; Kimura S; Sobue G
Acta Neuropathol; 2003 Mar; 105(3):217-24. PubMed ID: 12557007
[TBL] [Abstract][Full Text] [Related]
3. Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis.
Shimizu T; Tomita Y; Son K; Nishinarita S; Sawada S; Horie T
Clin Rheumatol; 2000; 19(5):352-9. PubMed ID: 11055823
[TBL] [Abstract][Full Text] [Related]
4. Chemokine-like factor expression in the idiopathic inflammatory myopathies.
Chowdhury MH; Nagai A; Terashima M; Sheikh A; Murakawa Y; Kobayashi S; Yamaguchi S
Acta Neurol Scand; 2008 Aug; 118(2):106-14. PubMed ID: 18294340
[TBL] [Abstract][Full Text] [Related]
5. Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.
Kim GT; Cho ML; Park YE; Yoo WH; Kim JH; Oh HJ; Kim DS; Baek SH; Lee SH; Lee JH; Kim HY; Kim SI
Clin Rheumatol; 2010 Mar; 29(3):273-9. PubMed ID: 19953283
[TBL] [Abstract][Full Text] [Related]
6. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production.
Sugiura T; Kawaguchi Y; Harigai M; Takagi K; Ohta S; Fukasawa C; Hara M; Kamatani N
J Immunol; 2000 Jun; 164(12):6593-600. PubMed ID: 10843719
[TBL] [Abstract][Full Text] [Related]
7. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis.
Sugiura T; Murakawa Y; Nagai A; Kondo M; Kobayashi S
Arthritis Rheum; 1999 Feb; 42(2):291-8. PubMed ID: 10025923
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis and VEGF-expressing cells are identified predominantly in the fascia rather than in the muscle during the early phase of dermatomyositis.
Yoshida K; Ito H; Furuya K; Ukichi T; Noda K; Kurosaka D
Arthritis Res Ther; 2017 Dec; 19(1):272. PubMed ID: 29216907
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis.
Goebels N; Michaelis D; Engelhardt M; Huber S; Bender A; Pongratz D; Johnson MA; Wekerle H; Tschopp J; Jenne D; Hohlfeld R
J Clin Invest; 1996 Jun; 97(12):2905-10. PubMed ID: 8675705
[TBL] [Abstract][Full Text] [Related]
10. Expression of tumor necrosis factor-alpha in muscles of polymyositis.
Tateyama M; Nagano I; Yoshioka M; Chida K; Nakamura S; Itoyama Y
J Neurol Sci; 1997 Feb; 146(1):45-51. PubMed ID: 9077495
[TBL] [Abstract][Full Text] [Related]
11. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC
J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids.
Ulfgren AK; Grundtman C; Borg K; Alexanderson H; Andersson U; Harris HE; Lundberg IE
Arthritis Rheum; 2004 May; 50(5):1586-94. PubMed ID: 15146429
[TBL] [Abstract][Full Text] [Related]
13. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.
Lundberg I; Ulfgren AK; Nyberg P; Andersson U; Klareskog L
Arthritis Rheum; 1997 May; 40(5):865-74. PubMed ID: 9153548
[TBL] [Abstract][Full Text] [Related]
14. Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents.
Loell I; Raouf J; Chen YW; Shi R; Nennesmo I; Alexanderson H; Dastmalchi M; Nagaraju K; Korotkova M; Lundberg IE
Arthritis Res Ther; 2016 Jun; 18(1):136. PubMed ID: 27287443
[TBL] [Abstract][Full Text] [Related]
15. Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity.
Ciccia F; Rizzo A; Alessandro R; Guggino G; Maugeri R; Saieva L; Cannizzaro A; Giardina A; De Leo G; Gerardo Iacopino D; Triolo G
Rheumatology (Oxford); 2014 Jul; 53(7):1307-12. PubMed ID: 24599919
[TBL] [Abstract][Full Text] [Related]
16. Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation.
Tateyama M; Fujihara K; Misu T; Arai A; Kaneta T; Aoki M
BMJ Open; 2015 Jan; 5(1):e006763. PubMed ID: 25582454
[TBL] [Abstract][Full Text] [Related]
17. Dual effects of caspase-1, interleukin-1 beta, tumour necrosis factor-alpha and nerve growth factor receptor in inflammatory myopathies.
Mackiewicz Z; Hukkanen M; Povilenaite D; Sukura A; Fonseca JE; Virtanen I; Konttinen YT
Clin Exp Rheumatol; 2003; 21(1):41-8. PubMed ID: 12673888
[TBL] [Abstract][Full Text] [Related]
18. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalization of protectin (CD59) and macrophages in polymyositis and dermatomyositis.
Gendek-Kubiak H; Gendek EG
J Neuroimmunol; 2004 Apr; 149(1-2):187-94. PubMed ID: 15020079
[TBL] [Abstract][Full Text] [Related]
20. The expression of cyclooxygenase-1, cyclooxygenase-2 and 5-lipoxygenase in inflammatory muscle tissue of patients with polymyositis and dermatomyositis.
Studýnková JT; Kuchen S; Jeisy E; Schedel J; Charvát F; Jarosová K; Sprott H; Matucci-Cerinic M; Gay RE; Michel BA; Pavelka K; Vencovský J; Gay S
Clin Exp Rheumatol; 2004; 22(4):395-402. PubMed ID: 15301234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
